New trial aims to spare rectums in early cancer with extra chemo
NCT ID NCT07563907
First seen May 21, 2026 · Last updated May 22, 2026 · Updated 1 time
Summary
This study tests whether adding a short course of chemotherapy (capecitabine) after standard chemoradiation but before a minor surgery (local excision) improves outcomes for people with stage I rectal cancer. About 292 participants will be randomly assigned to receive either standard treatment or standard treatment plus the extra chemo. The main goal is to see if the extra chemo leads to a complete disappearance of the tumor, while also monitoring side effects and quality of life.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TOTAL NEOADJUVANT TREATMENT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Seoul National University Hospital
Seoul, Jongro-gu, 03080, South Korea
Conditions
Explore the condition pages connected to this study.